insights_auto
Why is ARQT down 4,31%?
Dive Deeperchevron_right
ARQT:NASDAQ
Arcutis Biotherapeutics Inc
25,29 US$
arrow_downward
-4,31%(-1,14) 1D
25,29 US$
0,00% (0,00)
bedtimeAfter hours
Closed: 1 ოქტ, 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARQT...
Open
26,10 US$
High
26,44 US$
Low
25,22 US$
Mkt. cap
3,18 მლრდ.
Avg. vol.
2,93 მლნ.
Volume
1,64 მლნ.
P/E ratio
117,90
52-wk high
31,77 US$
52-wk low
19,30 US$
EPS
0,21 US$
Beta
1,50
Shares outstanding
125,69 მლნ.
No. of employees
354
Open
26,10 US$
High
26,44 US$
Low
25,22 US$
Mkt. cap
3,18 მლრდ.
Avg. vol.
2,93 მლნ.
Volume
1,64 მლნ.
P/E ratio
117,90
52-wk high
31,77 US$
52-wk low
19,30 US$
EPS
0,21 US$
Beta
1,50
Shares outstanding
125,69 მლნ.
No. of employees
354
News stories
From web sources and news partners
Zacks
·
9 საათის წინ
Merck's Tulisokibart Meets Endpoints in Hidradenitis Suppurativa Study
About Arcutis Biotherapeutics Inc
CEOფრენკ ვატანაბე
Employees354
Founded2016
HeadquartersWestlake Village, კალიფორნია, ამერიკის შეერთებული შტატები
Sector-
Websitearcutis.com